Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.70% | 38.50% | 32.56% | 25.94% | 19.76% |
| Total Depreciation and Amortization | -15.64% | -10.22% | -5.50% | -1.41% | 2.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.64% | -24.54% | -2.27% | -13.07% | -6.26% |
| Change in Net Operating Assets | 111.72% | 83.79% | -317.54% | -3,223.16% | -181.40% |
| Cash from Operations | 57.11% | 50.95% | 27.52% | 11.47% | 12.15% |
| Capital Expenditure | 67.85% | 63.06% | 77.18% | 73.49% | 57.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.18% | -55.88% | 251.62% | 21.26% | 71.12% |
| Cash from Investing | -90.22% | -55.38% | 297.57% | 25.19% | 144.62% |
| Total Debt Issued | -1.48% | -1.48% | -1.48% | 100.22% | 3.84% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.07% | -91.56% | -91.63% | -78.10% | -79.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.52% | -48.64% | -48.67% | 55.48% | 34.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 204.65% | 15.57% | 1,143.70% | 1,282.22% | 94.77% |